Influence of different levels of dissolved oxygen on the success of Greenland halibut (Reinhardtius hippoglossoides) egg hatching and embryonic development

The aim of this study was to determine the influence of different levels of dissolved oxygen (DO) on embryonic development (ED) and hatching success of Greenland halibut (Reinhardtius hippoglossoides) eggs. Fertilized eggs from six females were exposed to five DO levels: severely hypoxic (10 and 20?%sat [percent saturation]), moderately hypoxic (35 and 50?%sat), and normoxic (100?%sat). Greenland halibut eggs were highly tolerant to hypoxia, with hatching occurring at levels as low as 20?%sat. In severely hypoxic conditions (10?%sat), ED was impaired and no hatching occurred. Lipid composition, during ED, changed as a function of female origin and DO levels. Phospholipids were the dominant lipid class in eggs. Although triacylglycerols were a minor lipid class in terms of abundance, they were only used under severe hypoxia. The results suggest that severe hypoxia (between 10 and 20?%sat) has detrimental effect on the early development of Greenland halibut and may result in reduced recruitment and lower population abundance if the decreasing trend in the DO levels observed in the bottom waters of the Gulf of St. Lawrence continues in the future. Other species that share similar life histories may also be at risk.     

The liver but not the skin is the site for conversion of a red carotenoid in a passerine bird

Carotenoids may provide numerous health benefits and are also responsible for the integumentary coloration of many bird species. Despite their importance, many aspects of their metabolism are still poorly known, and even basic issues such as the anatomical sites of conversion remain controversial. Recent studies suggest that the transformation of carotenoid pigments takes place directly in the follicles during feather growth, even though the liver has been previously recognised as a storing organ for these pigments with a certain potential for conversion. In this context, we analysed the carotenoid profile of plasma, liver, skin and feathers of male Common Crossbills (Loxia curvirostra). Interestingly, the derivative feather pigment 3-hydroxy-echinenone was detected in the liver and in the bloodstream (i.e. the necessary vehicle to transport metabolites to colourful peripheral tissues). Our results demonstrate for the first time with empirical data that the liver may act as the main site for the synthesis of integumentary carotenoids. This finding contradicts previous assumptions and raises the question of possible inter-specific differences in the site of carotenoid conversion in birds.     

Twelve years of assessing the quality of preimplantation genetic testing for monogenic disorders

Objective

Genomics Quality Assessment has provided external quality assessments (EQAs) for preimplantation genetic testing (PGT) for 12 years for eight monogenic diseases to identify sub-optimal PGT strategies, testing and reporting of results, which can be shared with the genomics community to aid optimised standards of PGT services for couples.

Method

The EQAs were provided in two stages to mimic end-to-end protocols. Stage 1 involved DNA feasibility testing of a couple undergoing PGT and affected proband. Participants were required to report genotyping results and outline their embryo testing strategy. Lymphoblasts were distributed for mock embryo testing for stage 2. Submitted clinical reports and haplotyping results were assessed against peer-ratified criteria. Performance was monitored to identify poor performance.

Results

The most common testing methodology was short tandem repeat linkage analysis (59%); however, the adoption of single nucleotide polymorphism-based platforms was observed and a move from blastomere to trophectoderm testing. There was a variation in testing strategies, assigning marker informativity and understanding test limitations, some clinically unsafe. Critical errors were reported for genotyping and interpretation.

Conclusion

EQA provides an overview of the standard of preimplantation genetic testing-M clinical testing and identifies areas of improvement for accurate detection of high-risk embryos.